[Self-management of anticoagulation therapy].
Patents on anticoagulation therapy benefit appreciably from so-called coagulation self-management. Thus, in comparison with patients receiving conventional management, self-managers showed a higher level of treatment quality, better compliance and a lower complication rate (ESCAT studies). In addition, self-monitoring permits greater flexibility and independence, quality of life improves, and the doctor-patient relationship benefits. Appropriate devices have been available in Germany since 1994. A prerequisite for the payment of the costs by health insurances is the participation of the patient in a theoretical and practical educational program, and his/her presumed life-long need for anticoagulation therapy.
Diehm
C
C
SRH-Klinikum Karlsbad-Langensteinbach gGmbH. curt.diehm@kkl.srh.de
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001780:Blood Coagulation Tests; D006801:Humans; D010349:Patient Compliance; D010353:Patient Education as Topic; D010817:Physician-Patient Relations; D011788:Quality of Life; D012648:Self Care; D013925:Thromboplastin
D000925:Anticoagulants; D013925:Thromboplastin